BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
POMPANO BEACH, FLORIDA, December 13, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.
